Partial albinism.
Comings DE, Odland GF.
JAMA. 1966 Feb 14;195(7):519-23.
Albinism, partial albinism, and vitiligo.
KUGELMAN TP, LERNER AB.
Yale J Biol Med. 1961 Jun;33(6):407-14.
[Waardenburg's Syndrome Type IIA with Partial Albinism].
Knebel D, Rudolph G, Herold T, Priglinger S.
Klin Monbl Augenheilkd. 2022 Dec;239(12):1467-1470. doi: 10.1055/a-1610-9690. Epub 2021 Sep 27.
Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature.
Mancini AJ, Chan LS, Paller AS.
J Am Acad Dermatol. 1998 Feb;38(2 Pt 2):295-300. doi: 10.1016/s0190-9622(98)70568-7.
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited.
Henter JI, Sieni E, Eriksson J, Bergsten E, Hed Myrberg I, Canna SW, Coniglio ML, Cron RQ, Kernan KF, Kumar AR, Lehmberg K, Minoia F, Naqvi A, Ravelli A, Tang YM, Bottai M, Bryceson YT, Horne A, Jordan MB.
Blood. 2024 Nov 28;144(22):2308-2318. doi: 10.1182/blood.2024025077.
[Oculocutaneous and ocular albinism].
Kubasch AS, Meurer M.
Hautarzt. 2017 Nov;68(11):867-875. doi: 10.1007/s00105-017-4061-x.
Partial albinism.
SMITH NG, SCHULZ J.
AMA Arch Derm. 1955 Apr;71(4):468-70. doi: 10.1001/archderm.1955.01540280044009.
Partial albinism.
ANSARI MY.
J Indian Med Assoc. 1960 Jan 16;34:49-51.
Partial albinism and immunodeficiency in patients with Hermansky-Pudlak Type II: Introducing 2 novel mutations.
Alizadeh Z, Nabilou S, Mazinani M, Tajik S, Hamidieh AA, Houshmand M, Fazlollahi MR, Pourpak Z.
Scand J Immunol. 2021 Jan;93(1):e12966. doi: 10.1111/sji.12966. Epub 2020 Sep 14.
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism.
Dotta L, Parolini S, Prandini A, Tabellini G, Antolini M, Kingsmore SF, Badolato R.
Orphanet J Rare Dis. 2013 Oct 17;8:168. doi: 10.1186/1750-1172-8-168.
